Haloperidol plasma levels and clinical response in paranoid schizophrenics.

Autor: Linkowski, Paul, Hubain, Philippe, Frenckell, Remy, Mendlewicz, Julien
Zdroj: European Archives of Psychiatry & Neurological Sciences; 1984, Vol. 234 Issue 4, p231-236, 6p
Abstrakt: The relationship between haloperidol plasma levels, plasma prolactin, and therapeutic efficacy was evaluated in 20 paranoid schizophrenics in a fixed-dose study for 6 weeks. We found a significant intrapatient cross-correlation of therapeutic efficacy, as measured by decrease in MSS and BPRS rating scales and time-dependent haloperidol and pro lactin changes, which were tested at weekly intervals. However, no significant curvilinear relationship was present between steady-state haloperidol plasma levels and MSS and BPRS improvement scores. Our data do not furnish clear-cut evidence in favor of the existence of a therapeutic window for haloperidol plasma levels in paranoid schizophrenia. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index